These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3896138)

  • 21. Liposomes in treatment of infectious diseases.
    Emmen F; Storm G
    Pharm Weekbl Sci; 1987 Jun; 9(3):162-71. PubMed ID: 3302929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators.
    Killion JJ; Fidler IJ
    Pharmacol Ther; 1998 Jun; 78(3):141-54. PubMed ID: 9690815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral and immunomodulatory activities of ascorbic acid.
    Jariwalla RJ; Harakeh S
    Subcell Biochem; 1996; 25():213-31. PubMed ID: 8821976
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of immunopotentiating agents on alveolar macrophage properties.
    Charley B
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):155-9. PubMed ID: 3539492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
    Daemen T; Veninga A; Dijkstra J; Scherphof G
    J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
    Szebeni J; Wahl SM; Betageri GV; Wahl LM; Gartner S; Popovic M; Parker RJ; Black CD; Weinstein JN
    AIDS Res Hum Retroviruses; 1990 May; 6(5):691-702. PubMed ID: 2163269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human mononuclear phagocyte system reunited.
    Haniffa M; Bigley V; Collin M
    Semin Cell Dev Biol; 2015 May; 41():59-69. PubMed ID: 25986054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The monocyte-macrophage system and acquired immunodeficiency syndrome (AIDS)].
    Ercoli L; Perno CF; Bergamini A; Rocchi G
    Medicina (Firenze); 1990; 10(1):1-8. PubMed ID: 2199742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Elements of the systems approach in studying and using antiviral preparations].
    Pshenichnov VA
    Vopr Virusol; 1989; 34(2):139-45. PubMed ID: 2669332
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats.
    Zhou X; Luo YC; Ji WJ; Zhang L; Dong Y; Ge L; Lu RY; Sun HY; Guo ZZ; Yang GH; Jiang TM; Li YM
    PLoS One; 2013; 8(9):e74390. PubMed ID: 24069305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for studying antiviral functions of macrophages and mononuclear phagocytes.
    Keller F
    J Immunol Methods; 1994 Sep; 174(1-2):167-72. PubMed ID: 8083518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liposomes as delivery systems in the prevention and treatment of infectious diseases.
    Bergers JJ; ten Hagen TL; van Etten EW; Bakker-Woudenberg IA
    Pharm World Sci; 1995 Jan; 17(1):1-11. PubMed ID: 7719272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.
    Verma JN; Rao M; Amselem S; Krzych U; Alving CR; Green SJ; Wassef NM
    Infect Immun; 1992 Jun; 60(6):2438-44. PubMed ID: 1587611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocytes and Macrophages as Viral Targets and Reservoirs.
    Nikitina E; Larionova I; Choinzonov E; Kzhyshkowska J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.